This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.00970-07v1 81/19/10558    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Joseph, T. Articles by Subbarao, K. Search for Related Content PubMed PubMed Citation Articles by Joseph, T. Articles by Subbarao, K.

 Previous Article  |  Next Article 

Journal of Virology, October 2007, p. 10558-10566, Vol. 81, No. 19
0022-538X/07/$08.00+0     doi:10.1128/JVI.00970-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Evaluation of Replication and Pathogenicity of Avian Influenza A H7 Subtype Viruses in a Mouse Model

Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland 20892,¹ MedImmune Vaccines, Inc., Mountain View, California 94043²

Received 4 May 2007/ Accepted 6 July 2007

Avian influenza A H7 subtype viruses pose a significant threat to human health because of their ability to transmit directly from domestic poultry to humans and to cause disease and, sometimes, death. Although it is important to develop vaccines against viruses of this subtype, very limited information is available on the immune response and pathogenesis of H7 viruses in animal models such as mice and ferrets. Ten H7 viruses were selected for possible vaccine development on the basis of their phylogenetic relationships and geographical locations. The virulence of the 10 viruses for mice and the immunogenicity of the viruses in mice and ferrets were evaluated to study the extent of antigenic relatedness and the level of cross-reactivity of antibodies. Most of the viruses showed similar patterns of cross-reactivity with mouse and ferret antisera. The Eurasian viruses elicited broadly cross-reactive antibodies that neutralized viruses from both Eurasian and North American lineages, but the converse was not true. A subset of the viruses was also evaluated for the ability to replicate and cause disease in BALB/c mice following intranasal administration. H7 subtype viruses were able to infect mice without adaptation and manifested different levels of lethality and kinetics of replication. On the basis of phylogenetic data, induction of broadly cross-neutralizing antibodies in mouse and ferret antisera, and their ability to replicate in mice, we have selected A/Netherlands/219/03 (subtype H7N7) and A/chicken/BC/CN-7/04 (subtype H7N3) viruses for vaccine development. The mouse model can be used for the preclinical evaluation of these vaccines against H7 subtype viruses.

Published ahead of print on 18 July 2007.